Hereditary Angioedema

Hereditary Angioedema: Symptoms, Causes, Types, Diagnosis, and Treatments

Hereditary Angioedema (HAE) is a rare but potentially life-threatening genetic disorder characterized by episodes of severe swelling in various parts of the body. These episodes can affect the skin, gastrointestinal tract, and upper airways, often occurring without warning and progressing rapidly. While HAE is not commonly seen in the general population, it carries significant implications for those who inherit it, impacting daily life, emotional well-being, and overall health.

In this comprehensive article, we will delve into the key aspects of Hereditary Angioedema, including its symptoms, causes, types, diagnosis methods, and treatment options, providing you with a full understanding of the condition and current strategies to manage it effectively.

What is Hereditary Angioedema?

Hereditary Angioedema is a genetic disorder that causes recurrent episodes of angioedema—swelling that typically occurs beneath the skin or mucous membranes. Unlike allergic reactions, HAE swelling is not associated with hives or itching and does not respond to antihistamines or corticosteroids. The swelling episodes can be painful and dangerous, especially when they involve the airways.

HAE affects approximately 1 in 50,000 people worldwide and is inherited in an autosomal dominant pattern. This means a child has a 50% chance of inheriting the condition if one parent is affected.

Symptoms of Hereditary Angioedema

The symptoms of HAE usually begin during childhood or adolescence and may worsen over time. Although the frequency and severity of attacks vary, the hallmark of the condition is episodic swelling. Common symptoms include:

1. Swelling of the Skin

Most commonly affects the hands, feet, face, and genitals.
Swelling is non-itchy, non-pitting, and can last from 2 to 5 days.
Often associated with pain and tightness.

2. Abdominal Attacks

Intense abdominal pain is a frequent symptom due to intestinal wall swelling.
Nausea, vomiting, and diarrhea may accompany the pain.
Symptoms may mimic surgical emergencies like appendicitis.

3. Airway Swelling

This is the most dangerous manifestation.
Swelling of the larynx or tongue can lead to airway obstruction.
Symptoms include hoarseness, difficulty breathing, and stridor.

4. Fatigue and Malaise

Fatigue may occur before or during an attack.
General feeling of being unwell is reported by many patients.

5. Prodromal Symptoms

Some individuals report a tingling sensation, skin tightness, or fatigue hours before an attack.
A serpiginous erythema (wavy rash) may precede swelling in some cases.

Causes of Hereditary Angioedema

HAE is caused by genetic mutations that lead to abnormalities in the regulation of a protein called C1 inhibitor (C1-INH). This protein controls several systems in the body, including the complement system, the kallikrein-kinin system, and the coagulation pathways.

There are two major causes based on genetic mutations:

1. C1-INH Deficiency or Dysfunction

Most common cause.
Results from mutations in the SERPING1 gene, which encodes C1-INH.
Leads to excessive production of bradykinin, a peptide that increases vascular permeability, causing fluid to leak into surrounding tissues.

2. Unknown Genetic Mutations

In Type III HAE, mutations are not always related to C1-INH.
Some involve the Factor XII gene, affecting bradykinin regulation.
Research continues to uncover additional mutations.

Types of Hereditary Angioedema

There are three main types of HAE, categorized by C1-INH levels and function:

Type I HAE

Accounts for approximately 85% of cases.
Characterized by low levels of C1-INH.
Caused by a mutation in the SERPING1 gene.
Reduced C1-INH results in increased bradykinin, leading to swelling.

Type II HAE

Around 15% of cases.
Normal or elevated levels of C1-INH, but the protein is dysfunctional.
Also caused by SERPING1 gene mutations.

Type III HAE

Also called HAE with normal C1-INH.
C1-INH levels and function are normal.
Mostly affects females and is linked to Factor XII gene mutations.
Triggers may include estrogen-containing medications and stress.

Diagnosis of Hereditary Angioedema

Early and accurate diagnosis is essential to prevent mismanagement and reduce life-threatening complications. Diagnosis involves a combination of clinical evaluation, family history, and laboratory tests.

Clinical Evaluation

History of recurrent, unexplained swelling without urticaria.
Symptoms starting in childhood or adolescence.
Swelling not responding to antihistamines or steroids.

Laboratory Testing

C4 Levels
- C4 is usually low during and between attacks.
- Used as an initial screening test.
C1-INH Levels
- Measured to differentiate between Type I and II.
- Low levels indicate Type I.
- Normal levels with poor function indicate Type II.
C1-INH Function Test
- Evaluates the activity of C1-INH protein.
- Helps confirm diagnosis when levels are ambiguous.
Genetic Testing
- Identifies mutations in SERPING1 or Factor XII genes.
- Useful in confirming diagnosis and for family screening.
Family History
- A strong family history of similar symptoms supports hereditary cause.
- However, 25% of cases are de novo mutations with no family history.

Treatment of Hereditary Angioedema

The management of HAE includes acute treatment of attacks, short-term prophylaxis before triggering events (e.g., surgery), and long-term prophylaxis to prevent frequent episodes.

1. Acute Treatment

Medications aim to quickly reduce swelling and prevent complications:

a. C1-INH Replacement Therapy

Berinert, Cinryze: Derived from human plasma.
Effective in reducing symptoms rapidly.
Administered intravenously.

b. Icatibant (Firazyr)

Bradykinin B2 receptor antagonist.
Subcutaneous injection.
Rapid onset of action.

c. Ecallantide (Kalbitor)

Kallikrein inhibitor.
Subcutaneous injection.
Must be administered by a healthcare professional due to risk of anaphylaxis.

2. Short-Term Prophylaxis

Before surgical or dental procedures that may trigger attacks.
C1-INH concentrate is usually administered prior to the procedure.
Danazol or tranexamic acid may be used in some cases.

3. Long-Term Prophylaxis

Recommended for patients with frequent or severe attacks:

a. C1-INH Prophylactic Therapy

Regular infusions (e.g., Cinryze) to maintain adequate C1-INH levels.
Reduces frequency and severity of attacks.

b. Lanadelumab (Takhzyro)

Monoclonal antibody that inhibits plasma kallikrein.
Subcutaneous injection every 2-4 weeks.
Well-tolerated and effective.

c. Berotralstat (Orladeyo)

Oral kallikrein inhibitor taken daily.
Offers convenient option for prophylaxis.

d. Attenuated Androgens (e.g., Danazol)

Used historically for prophylaxis.
Reduce frequency of attacks by increasing hepatic production of C1-INH.
Associated with significant side effects: weight gain, virilization, liver toxicity.
Now used only when newer therapies are unavailable or unsuitable.

Lifestyle and Management Tips

Although HAE is a lifelong condition, many patients lead normal lives with the right treatment and precautions.

1. Avoid Known Triggers

Physical trauma, stress, infections, and certain medications (e.g., ACE inhibitors, estrogen) can provoke attacks.
Minimize exposure to these triggers when possible.

2. Education and Emergency Preparedness

Patients and caregivers should know how to recognize early signs of an attack.
Carrying emergency medication and a medical ID card is essential.
Keep a written action plan for managing attacks.

3. Psychological Support

Chronic illnesses often lead to anxiety and depression.
Psychological counseling and support groups can improve mental health and quality of life.

4. Genetic Counseling

Family members should be offered genetic testing.
Counseling helps in understanding inheritance patterns and reproductive choices.

Prognosis and Outlook

With advancements in targeted therapies and increased awareness, the prognosis for HAE has significantly improved. Most patients can control their symptoms and avoid life-threatening complications through personalized treatment plans. However, early diagnosis and proper medical care remain crucial in preventing misdiagnosis and managing this rare condition effectively.

Conclusion

Hereditary Angioedema, though rare and potentially dangerous, can be effectively managed with a clear understanding of its nature, symptoms, and treatment options. With advancements in medical therapies and increased public awareness, individuals with HAE are now empowered to take control of their health and lead fulfilling lives.

If you or a loved one experiences unexplained swelling episodes, especially with a family history of similar symptoms, seeking medical attention for evaluation and testing is critical. Early diagnosis not only improves outcomes but also ensures that life-saving treatment is accessible when needed.

🧠 Frequently Asked Questions (FAQs) About Hereditary Angioedema

What is Hereditary Angioedema (HAE)?

Hereditary Angioedema is a rare genetic disorder that causes sudden and recurrent swelling in various parts of the body, including the limbs, face, intestinal tract, and airway, due to a deficiency or dysfunction of the C1 inhibitor protein.

How is HAE different from an allergic reaction?

Unlike allergic swelling, HAE is not triggered by allergens and does not respond to antihistamines, corticosteroids, or epinephrine. The swelling is deeper, lasts longer, and occurs without hives.

What causes Hereditary Angioedema?

HAE is caused by mutations in the SERPING1 gene, leading to low levels or poor function of the C1 inhibitor protein. This imbalance results in excessive bradykinin production, which causes blood vessels to leak fluid and leads to swelling.

Is Hereditary Angioedema inherited?

Yes, HAE is usually inherited in an autosomal dominant pattern, meaning a child has a 50% chance of inheriting the condition if one parent is affected. However, some cases occur due to spontaneous mutations.

What are the symptoms of HAE?

Common symptoms include non-itchy swelling of the face, hands, feet, genitals, or throat, abdominal pain, nausea, vomiting, and in severe cases, airway obstruction that can be life-threatening.

When do HAE symptoms usually begin?

Symptoms typically start in childhood or adolescence, but the severity and frequency of attacks can vary greatly from person to person.

How is HAE diagnosed?

Diagnosis involves measuring levels and function of the C1 inhibitor protein and complement component C4 in the blood. Genetic testing may also be used to confirm the diagnosis and identify mutations.

Can HAE be misdiagnosed?

Yes, due to its rare nature and overlap with allergic or gastrointestinal conditions, HAE is often misdiagnosed—especially when abdominal pain is the primary symptom.

Is there a cure for Hereditary Angioedema?

There is currently no cure for HAE, but it can be effectively managed with medications that prevent or treat swelling episodes and reduce their frequency and severity.

What treatments are available for HAE?

Treatment options include C1 inhibitor replacement therapy, bradykinin receptor antagonists (like icatibant), kallikrein inhibitors (like lanadelumab), and prophylactic medications to prevent attacks.

Are HAE attacks life-threatening?

Yes, swelling of the throat or upper airway can block breathing and become a medical emergency. Immediate treatment is crucial during such episodes.

Can stress or hormones trigger HAE attacks?

Yes, common triggers include physical trauma, emotional stress, infections, menstruation, and hormonal changes. Certain medications like estrogen or ACE inhibitors can also provoke attacks.

Can women experience more severe HAE symptoms?

Yes, hormonal fluctuations can affect the severity and frequency of attacks. Estrogen-containing medications can worsen symptoms, especially in women with HAE type III.

What should I do during an HAE attack?

Seek medical attention immediately if the swelling affects the throat. Use your prescribed emergency medication (such as icatibant or C1-INH concentrate) and follow your doctor’s action plan.

Can people with HAE live a normal life?

With modern treatments and proactive management, most people with HAE can live active, full lives. Early diagnosis and personalized care make a significant difference in quality of life.

For more details keep visiting our Website & Facebook Page.